logo

For the Inventor, By the Inventor

Jona, Switzerland

Teva Pharmaceuticals International Gmbh

USPTO Granted Patents = 54

% Expired Patents = 20.4



Trademarks = 12

Forward Citations = 213

Loading Chart...
Loading Chart...

141 inventors (with patents filed for the assignee):

goldMedal Marcelo Bigal (8 out of 8 patents)

silverMedal Kristian Todd Poulsen (7 out of 23 patents)

bronzeMedal Joerg Zeller (7 out of 21 patents)

4.  Arnon Rosenthal (5 out of 122 patents)

5.  Jaume Pons (5 out of 59 patents)

6.  Yasmina Noubia Abdiche (5 out of 25 patents)

7.  Sierra Jones Collier (5 out of 13 patents)

8.  Ernesto Aycardi (4 out of 4 patents)

9.  Terri Sebree (4 out of 27 patents)

10.  Sarah Walter (4 out of 5 patents)

11.  Henry Stern (4 out of 4 patents)

12.  Michael Chang (4 out of 4 patents)

13.  Roman Gabriel (3 out of 13 patents)

14.  Pavel Kolesa (3 out of 5 patents)

15.  Rudolf-Giesbert Alken (3 out of 5 patents)


Core Competencies:
Belumosudil
Migraine Treatment
Solid State Forms
Olanazapine
Sofosbuvir
Antibody Therapy
Iontophoretic Delivery
Pharmaceutical Compositions
Dopamine Modulators
Pain Management
Transdermal Systems
Crystalline Polymorphs

54 patents:

1. 12157729 - Solid state forms of Belumosudil and Belumosudil salts (2024-12-03),
2. 12139528 - Treating refractory migraine (2024-11-12),
3. 12091388 - Solid state forms of Reproxalap (2024-09-17),
4. 11813359 - Sustained release olanzapine formulations (2023-11-14),
5. 11773083 - Solid state forms of Belumosudil and Belumosudil salts (2023-10-03),
6. 11760757 - Solid state forms of lumateperone ditosylate salt (2023-09-19),
7. 11673860 - Crystalline siponimod fumaric acid and polymorphs thereof (2023-06-13),
8. 11555064 - Treating headache comprising administering an antibody to calcitonin gene-related peptide (2023-01-17),
9. 11541177 - Injection spring for aged prefilled syringe and auto injector (2023-01-03),
10. 11420945 - Solid state forms of Pemafibrate (2022-08-23),
11. 11332469 - Solid state forms of lumateperone ditosylate salt (2022-05-17),
12. 11306104 - Solid state forms of Relugolix (2022-04-19),
13. 11220488 - Crystalline polymorph of Ponesimod (2022-01-11),
14. 11053261 - Solid state forms of ixazomib citrate (2021-07-06),
15. 11028161 - Treating refractory migraine (2021-06-08),
Company Overview
Teva Pharmaceuticals International GmbH, based in Jona, Switzerland, specializes in the development and manufacturing of pharmaceutical formulations. The company focuses on innovative therapies across various domains, including migraine treatment and antibody therapy. Teva is recognized for its advancements in solid state forms and iontophoretic delivery systems, as well as its work with compounds like Belumosudil, Olanazapine, and Sofosbuvir. Its commitment to improving patient outcomes drives its research in pharmaceutical compositions and therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Teva Pharmaceuticals International Gmbh USPTO Patent Assignee Logo
54 Patents

#4 in Jona

#296 in Switzerland

#13,140 in the World

Jona, CH
Jona, Switzerland

Teva Pharmaceuticals International Gmbh

Forward Citations = 213

141 inventors:

goldMedal Marcelo Bigal (8 out of 8 patents)

silverMedal Kristian Todd Poulsen (7 out of 23 patents)

bronzeMedal Joerg Zeller (7 out of 21 patents)

4.  Arnon Rosenthal (5 out of 122 patents)

5.  Jaume Pons (5 out of 59 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Teva Pharmaceuticals International Gmbh. Retrieved from https://idiyas.com/company/teva-pharmaceuticals-international

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…